Dexcom Inc risk profile
37 Normal where most of the sector sits
Measured 21 October 2026 from DXCM's filed statements. Recomputed nightly.
37 (Normal), driven by Concentration at 69, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 30 | Normal | Stable | One-year price volatility — 39.6% |
| Operating pressure | 24 | Normal | Easing | Operating-margin drift — +6.1 percentage points |
| Cash conversion | 20 | Normal | Stable | Capital spending against operating cash — 0.25x |
| Leverage and coverage | 10 | Contained | Easing | Current ratio — 1.88x |
| Competitive position | 37 | Normal | Stable | Operating-margin gap against peers — +7.7 percentage points |
| Concentration | 69 | Stretched | Stable | Geographic concentration — 5,117 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.